INTRODUCTION
Microdialysis is a well-established technique for the continuous sampling of small water-soluble molecules within the extracellular fl uid space in vivo. It has an advantage over other sampling techniques in that it can be used to follow temporal variations in the generation and release of a substance at a discreet location within the tissue space. Since its initial use in the brain of experimental animals for the recovery of neurotransmitters and other small hydrophilic solutes, 1 microdialysis has been adapted for use in many other tissues, including skin, 2-9 adipose tissue, 10 muscle, 11 , 12 and gastrointestinal tract. 13 However, the ability to recover molecules of higher molecular mass has, until recently, been limited by the availability of dialysis probes with high molecular weight cutoffs (MWCOs).
The development of membranes suitable for the recovery of large molecules has been driven by the need to sample the extracellular fl uid space for bioactive proteins and regulatory peptides as markers of tissue homeostasis and, more important in a clinical setting, tissue dysfunction and repair. This brief review will consider how recent studies have advanced the understanding of the process by which large molecules are recovered by dialysis and how this may be applied to the use of such probes in clinical settings in the future.
PRINCIPLES OF DIALYSIS OF LARGE MOLECULES
Some of the fi rst researchers to report the successful recovery of large molecules by microdialysis used a polycarbonate membrane extracted from a plasmapheresis capsule (Plasmafl o, OP-02 Asahi Medical Co Ltd, Kimal plc Bromsgrove, Worcs UK) confi gured as a linear, fl owthrough dialysis probe. These membranes had an MWCO of 300 000 Da and a maximum pore size of 0.3 µm, as stated by the manufacturer. They were used experimentally in both animal models and humans confi gured as either a linear fl owthrough membrane or a concentric dialysis probe, to recover serum proteins, neuropeptides, cytokines, and growth factors. [14] [15] [16] Since then, commercially available polyethersulfone microdialysis probes with an MWCO of 6000 to 100 000 Da have been used to recover a wide range of molecular species ranging in size from 3000 to 120 000 Da. [17] [18] [19] [20] Some of these studies are summarized in Table 1 .
Theoretically, the probes at the higher end of the MWCO range may appear to be satisfactory for the dialysis of cytokines, growth factors, and even high -molecular mass serum proteins. Practically, however, the number of pores within most of the membranes currently used that are capable of allowing the passage of such large molecules is small and results in an increased mass transport resistance and a low relative recovery. For example, the dialysis effi ciency (E d ) of a 10 000-Da protein across a commercial 100 000-Da MWCO membrane perfused at a fl ow rate of 1 µL/min is typically below 5%. 30 There are also several experimental factors, including probe perfusion rate and duration, that may signifi cantly affect macromolecular recovery. This is illustrated by the in vitro dialysis of serum albumin (67 kDa) using a plasmapheresis membrane confi gured as a linear probe of 1.5 cm length, where E d decreases exponentially from 1.01 ± 0.02 at a perfusion rate of 0.1 µL/min to 0.17 ± 0.06 at perfusion rate of >5 µL/min ( Figure 1 ). The dialysis effi ciency for a molecule the size of serum albumin may be similarly compromised in vivo. This is evidenced by the fall in steady-state protein concentration recovered in dialysate from healthy skin from a value of 0.73 ± 0.30 mg/mL at a perfusion rate of 5 µL/min to 0.47 ± 0.19 mg/mL at 10 µL/min (P < .005) (Fellows et al, unpublished data, 2005) . However, while the dialysate protein concentration was lower at the higher perfusion rates, the total amount of analyte recovered over a 30-minute perfusion period was greater at the higher perfusion rates (192 ± 14 µL and 225 ± 38 µL at 5 and 10 µL/min, respectively), suggesting that it may be an interesting compromise between the demands of an assay for total amount of material and its requirements for a given minimum concentration or volume.
It should also be noted that continuous perfusion of largepore dialysis membranes for long periods results in an apparent fall in analyte recovery, with initial total protein levels signifi cantly higher than those recovered in later samples ( Figure 2 ). 23 One explanation for this is that the amount of material available for dialysis recovery falls with time. It is well recognized that the concentration gradient of any solute within the tissue space within the proximity of the probe will be determined by the rate at which it is supplied by, and diffuses through, the tissue and also by the rate at which it is removed in the dialysate. This phenomenon may be particularly true for larger, more slowly diffusing molecules at low biological concentrations within the tissue space.
Taken together, these factors suggest that for high -molecular mass solutes it is unlikely that even at very low rates of perfusion a diffusion equilibrium will be reached and a sample representative of the biological concentration of the analyte will be recovered. Figure 2 suggests that the concentration of total protein outside the probe calculated from the relationship
where C tissue and C outlet are the concentration of the solute in the tissue and outfl ow of the probe, PS is the permeabilitysurface area product for the dialysis membrane, and F is the perfusion rate 31 is initially between 25 and 30 mg/mL but falls to 4 to 6 mg/mL after extended periods of perfusion.
Although the initial values of total protein in dialysate approximate well to the published values for interstitial 
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protein content of between 12 and 30 mg/mL sampled using micropuncture, interstitial wicks, or blister fl uid, 32-34 the absolute amount of any analyte present in the tissue space cannot truly be estimated without calibration of the probe.
Another factor that will infl uence recovery of solute from the interstitial space is tissue hydration. Recovery may be attenuated by the loss of fl uid by ultrafi ltration across the highly porous membrane, particularly at high fl ow rates. Fluid loss into the tissue, as well as having the potential to compromise tissue function and stimulate changes in the tissue levels of the target molecules, may also dilute the content of the interstitial space. An increase in tissue water will reduce further the often low concentrations of the target molecules within the tissue space and may lead to an underestimate of the concentration of the molecules of interest. This is seen when the performance of large pore membranes placed at different tissue sites is compared. We have found that using the linear 300 000-Da MWCO membranes in healthy human skin, both the volume recovery and the total protein concentration of dialysate from probes placed on the ventral surface of the forearm, close to the wrist, differ signifi cantly from those measured using probes located more proximally. In these experiments on healthy volunteers, relative volume recovery measured over ten 3-minute collections fell from 1.04 ± 0.04 in probes placed in the upper forearm to 0.92 ± 0.05 in those placed distally close to the wrist (P < .02) (Clough et al, unpublished observations, 2005) .
Several groups have attempted to overcome fl uid loss into the tissue and to improve total volume recovery by the addition of osmotic agents to the probe perfusate. 28 , 35 These agents have included serum albumin and modifi ed starches, both of which tend to reduce fl uid loss into the tissue space. Some of the additives used have the added advantage of reducing nonspecifi c adsorption of analyte onto the material of the probe or act as binding agents to stabilize and enhance recovery of hydrophobic or highly tissue-bound molecules.
The ability to recover hydrophobic molecules by dialysis appears compromised by their adsorption onto the polymeric materials used to construct the probe and onto the membrane itself. 36 , 37 Consequently, the in vitro recovery of several cytokines, including interleukin 2 (IL-2), IL-4, IL-5, interferon gamma (IFN-␥ ), and tumor necrosis factor alpha (TNF ␣ ), has been reported to be as low as 1%. 25 , 29 For other cytokines, in vitro recovery effi ciencies of dialysis using a 300 000-Da membrane have been reported to be somewhat higher: 45% ± 8%, 28% ± 4%, and 22% ± 8% for IL-6, IL-1 ␤ , and nerve growth factor (NGF), respectively, compared with 17.5% ± 6% for serum albumin. 38 Recovery of cytokines has been enhanced experimentally by the addition to the probe perfusate of albumin, modifi ed starches (cyclodextrins), or lipids. 9 , 19 , 22 , 28 , 39 , 40 While the ability of these agents to increase recovery varies considerably and in vitro appears to depend on the nature of the dialysate membrane and the analyte, 9 E d may be enhanced such that in vivo, a cytokine that is undetectable using a saline perfusate is recovered in measurable amounts (10 -12 -10 -9 M) when bovine serum albumin (BSA) is added to the perfusate at concentrations of between 3.5% and 10% (mass-to-volume ratio). 28 Addition of antibody-coated microbeads to the probe perfusate can similarly enhance cytokine recovery by up to 1000% in vitro by trapping cytokine molecules and increasing the diffusive driving force across the probe membrane. 29 This has been particularly effective for TNF ␣ and IL-5, 2 infl ammatory cytokines that have proved particularly diffi cult to recover using saline perfusion of 300 000-Da membranes in vivo (Clough et al, unpublished data, 2005) . Whether these recovery enhancers are as effective in vivo as they appear to be in vitro has yet to be explored.
In summary, the consequence of these various physical restraints alone or in combination is that the amount of high -molecular mass material recovered in dialysate, even under optimal conditions, is frequently very low. Furthermore, the concentrations recovered in dialysate may be unrepresentative of tissue levels. Evidence for changes in macromolecular analyte levels from baseline may thus be more effectively sought than absolute values.
ANALYSIS PLATFORMS FOR LARGE MOLECULES IN DIALYSIS SAMPLES
The future of the application of microdialysis to the monitoring of large molecules as markers of disease in a prognostic or diagnostic setting depends very much on the ability to detect and assay them with suffi cient sensitivity and reproducibly. While the analytical methods used to detect lowmolecular mass solutes in dialysate have been extensively reviewed, 41 , 42 there are fewer reviews of the analysis platforms suitable for the detection of proteins in dial ysate. 43 As described above, the concentration of many of the proteins of interest is very low, in the nanogram to picogram per milliliter range. Until recently, the majority of studies have employed sensitive fl uorometric or radio or enzyme immunoassays, many used at the limits of their detection. The volume requirements of these assays are considerable and limit the number of proteins assayable within a single dialysate sample. 16 , 22 Sensitive temporal resolution of changes in protein levels at a given site within the tissue space may also be precluded if low perfusion rates and extended collection times are required. The advent of multiplexed cytokine arrays where 10 or more cytokines can be assayed using a 25 to 50 µL sample volume with a similar sensitivity to that of conventional immunoassays, has to some extent overcome this. 43 In Lee et al (unpublished data, 2004 ) own hands they have proved a useful platform for the analysis of the differential cytokine production in dialysate E689 E d of ~20%) appears somewhat lower than that reported using other techniques. However, the protein content of the samples collected within the fi rst 2 minutes of the start of perfusion are more than 5 times higher than this and close to those recovered in blister fl uid. 33 Similar or greater levels are also recovered during dermal provocation with agents known to induce plasma extravasation. 53 , 54 Microdialysis has been used to follow the upregulation of infl ammatory cytokines within the interstitial space in normal and infl amed skin. 22 , 24 , 55 It has also been used in breast tissue to investigate changes in angiogenic factors such as soluble vascular endothelial growth factor (VEGF) in health and during tumor angiogenesis 17 , 56 and to monitor changes within the environment of both acute and chronic wounds. 57 , 58 The wound environment has proved quite diffi cult to sample because of the nature of the wound exudate. In exudating chronic ulcers, the average dialysate protein concentration was found to be 0.5 mg/mL (Avery et al, unpublished data, 2005). By comparison, the concentration of protein in chronic wound fl uid obtained by direct sampling ranges from 26 to 51 mg/mL, with a mean (± standard deviation) of 38 ± 13 mg/mL, suggesting that dialysis efficiency for total protein is very low under these conditions. Interestingly, volume recovery was also much reduced, with less than 60% recovery using a 2-cm dialysis length of 300 000-Da plasmapheresis membrane confi gured as a loop to lie within the wound environment.
Recovery and detection of some markers of infl ammation anticipated to be present in infl amed skin, including TNF ␣ and IL-5, have proved problematic. Whether this is due to a reduced availability or concentration within the environment of the probe or due to adhesion of the bioactive molecule onto the material of the probe has yet to be confi rmed either in or ex vivo.
MICRODIALYSIS OF LARGE MOLECULES IN THE BRAIN
Intracerebral microdialysis has been used extensively as a research tool in the investigation of the neurochemical and metabolic changes that occur following acute brain injury. However, few studies have pursued the recovery of larger molecules, particularly cytokines, from the brain by microdialysis. Studies that have attempted to investigate cytokine levels in the traumatized brain have generally been limited to measurements within the cerebrospinal fl uid and serum of patients. Recently, we have reported that it is possible to recover high -molecular weight molecules from the parenchyma of the frontal lobe of the brain using a concentric version of the 300 000-Da MWCO microdialysis probe. 16 , 38 Samples were collected at intervals for periods of several hours during the patients ' stay in the intensive care unit. We found that the levels of IL-6 measured in outfl owing and in human skin with a spatial resolution of millimeters and temporal resolution of minutes.
Mass screening tools such as the recent proteomic approaches using mass spectrometry have been used to evaluate patterns of protein expression in a variety of tissue fl uids and to explore clinically useful biomarkers of disease. 45 These fl uids include plasma, cerebrospinal fl uid, 46 and urine. 47 Plasma is the body fl uid most extensively assayed because of its accessibility in which more than 175 candidate biomarker proteins with associations with cardiovascular disease have already been characterized. 45 , 48 , 49 Cerebrospinal fl uid has been probed using 2D gel electrophoresis to detect changes in protein expression patterns in patients with neurological or psychological disease. 46 2D gel electrophoresis in combination with mass spectrometry has also been used to investigate protein patterns in human cerebral microdialysate (see below). 18 In addition, cerebral dialysate in rats has been screened for endogenous neuropeptide generation using capillary liquid chromatography -tandem mass spectrometry. 20 These approaches, by which many proteins and peptides can be screened at one time, lend themselves to the identifi cation of novel proteins whose release can be correlated with different physiological, pathophysiological, or behavioral states. It is probable that the advent of commercial probes suitable for the recovery of large molecules will result in an increase in the application of such proteomic approaches to microdialysate samples. The analytical challenges, just as in plasma, will be (1) the depth of the tissue fl uid proteome, in which concentrations of protein biomarkers vary over many orders of magnitude; and (2) the breadth of the tissue fl uid proteome, with potentially many hundreds of bioactive markers.
MICRODIALYSIS SAMPLING OF PROTEINS IN SKIN
Various techniques have been used to sample the interstitial space in skin and to explore the changes in interstitial protein content under both physiological and pathophysiological conditions. These include the wick technique and the blister suction technique, which have been widely used in the skin for dermatological and pharmacokinetic studies. 33 , 50 , 51 They yield values for total interstitial protein concentration of between 18 and 27 g/L, or ~30% to 40% of that measured in plasma. Of this, 13 to 17 g/L is albumin. 32 Although recent studies have shown that there is a close correlation between the 2 techniques when used to sample the subcutaneous interstitial space in healthy human volunteers, neither particularly lends itself to monitoring rapid changes in tissue protein levels. Several groups have now used microdialysis to follow both spatial and temporal changes in interstitial fl uid protein content in resting and provoked skin, as discussed earlier. 6 , 52 Steady-state basal interstitial protein concentration (calculated assuming an the opportunity to recover larger bioactive molecules and protein-bound substrates that could otherwise be recovered in vivo. They allow monitoring of changes in interstitial levels of these molecules in a wide range of physiological and pathophysiological states. Microdialysis recovery of large molecules also offers the opportunity to identify patterns of protein expression in a variety of tissue spaces and to evaluate clinically useful biomarkers of disease. From all this may develop a better understanding of the disease process and its diagnosis and more targeted approaches to therapy. dialysis fl uid from 13 patients with traumatic brain injury correlated with survival outcome and were between 60 and 1230 pg/mL. NGF levels were between 180 and 2964 pg/mL, with a tendency for NGF levels to be higher in nonsurvivors. IL-1 ␤ (0 -140 pg/mL), by contrast, showed no association with clinical measures. Interestingly, total protein and albumin levels measured in dialysate remained relatively constant over periods of up to 5 days. Thus, it seems unlikely that the proteins/cytokines recovered may be consequent to local tissue damage caused by probe insertion. The levels of total protein in cerebral dialysate of ~100 µg/mL were 3-fold lower than those found in dialysis fl uid from the skin using the same membrane. This is consistent with the maintenance of the blood-brain barrier. However, the fi nding that ~70% of the total protein that was recovered in cerebral dialysate was albumin is in agreement with similar observations in the skin.
Maurer et al 18 have investigated patterns of global protein expression in cerebral dialysate from patients with stroke using a proteomic approach based on 2D gel electrophoresis and subsequent mass spectrometry. They mapped over 158 protein spots in the 2D gels, of which they identifi ed more than half. The 95 spots identifi ed by subsequent mass spectrometry and database search represented 27 individual proteins, 10 of which were exclusive to the dialysate and not present in cerebrospinal fl uid. Common to both were albumin, immunoglobulin (IgG) light and heavy chain, and various binding proteins. Specifi c to the dialysate were proteins that were brain-specifi c, such as the creatinine kinase B subunit and tubulin alpha-1, and others that might indicate disease severity or progression.
Of signifi cance in both this study 18 and that of Winter et al 16 is that raised levels of proteins and/or cytokines were detected far from the cerebral injury. It is unlikely that these molecules diffuse freely through the brain 59 and thence that the proteins recovered in the contralateral hemisphere originate from the damaged brain area. It seems more likely that the increases seen are indicative of altered pathology in the undamaged hemisphere and that they provide a biochemical marker of an endogenous response to a secondary diffuse-type damage occurring in the brain and may be important in determining clinical outcome. We do not have comparable values for parenchymal protein or cytokine levels in non -head injured controls, as it is currently not possible to sample dialysate in a " normal " brain, and so we cannot judge the effect that probe insertion itself has on cytokine levels.
CONCLUSION
In summary, while the high-MWCO membranes are harder to use than those with small pores and the recovery more subject to changes in the local environment, they do provide
